Human papillomavirus in head and neck cancer in India: Current status and consensus recommendations
Vedang Murthy(Homi Bhabha National Institute), Purvish Parikh(Heidelberg University), Manish Singhal(Indraprastha Apollo Hospitals), Monali Swain(Tata Memorial Hospital), Amit Bhatt(Apple (Israel)), Adnan Calcuttawala(Tata Memorial Hospital), Indranil Mallick(Tata Medical Center), Sudhir Nair(Homi Bhabha National Institute), Sanjoy Chatterjee(Tata Medical Center), Moni Abraham Kuriakose(R. G. Kar Medical College and Hospital), Asawari Patil(Tata Memorial Hospital), Kumar Prabhash(Homi Bhabha National Institute), Prasad Narayanan(HCG Cancer Hospital), Anil d’Cruz(Tata Memorial Hospital), Sagar Pawar(Advanced Centre for Treatment, Research and Education in Cancer), Kaustav Talapatra, Nikhil Ghadyalpatil(Cancer Institute (WIA)), Jaiprakash Agarwal(Tata Memorial Hospital), Arvind Krishnamurthy(Cancer Institute (WIA)), Kirti Chadha(Zydus Lifesciences Limited (India)), Tanuja Teni(Advanced Centre for Treatment, Research and Education in Cancer)
Cited by 48
Related Papers
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2008|3.2k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients
|International Journal of Radiation Oncology*Biology*Physics|2009|984
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694